Therapeutic drug monitoring in epilepsy: an alternative approach

Cover Page

Cite item

Full Text


Therapeutic drug monitoring is an important part of antiepileptic therapy, and the search for alternative non-invasive methods of such monitoring represents an actual task for clinical neurology. For this purpose, we determined by gas chromatography and mass spectroscopy the levels of the anticonvulsant carbamazepine in the plasma and saliva of healthy volunteers aged 18–25 years after one oral dose of 200 mg. Maximal drug concentration was 2.6–2.7 µg/ml in the plasma and 0.75 µg/ml in the saliva; mean saliva/plasma drug level ratio was 0.3. Time necessary to reach maximal concentration was 6–7 hrs for both plasma and saliva. T1/2 was also equal for both sources: 15–16 hrs. Significant correlation between the plasma and saliva carbamazepine concentrations was revealed (R2=0,893). Thus, while treating epilepsy patients with carbamazepine, it is possible to use the saliva as an adequate biological sample for conducting non-invasive drug monitoring.


About the authors

A. A. Rodyonov

Research Center of Neurology, Russian Academy of Medical Sciences

Russian Federation, Moscow

I. A. Kabanova

Research Center of Neurology, Russian Academy of Medical Sciences

Russian Federation, Moscow

R. D. Seifulla

Research Center of Neurology, Russian Academy of Medical Sciences

Russian Federation, Moscow

A. B. Timofeev

Research Center of Neurology, Russian Academy of Medical Sciences

Author for correspondence.
Russian Federation, Moscow


  1. Авакян Г.Н. Современные аспекты лечения эпилепсии. Атмосфера. Нервные болезни. 2005; 4: 4–8.
  2. Бондарева И.Б. Математическое моделирование в фармакокинетике и фармакодинамике. Дис. … докт. биол. наук. М., 2001.
  3. Гусев Е.И., Белоусов Ю.Б., Гехт А.Б. Лечение эпилепсии: рациональное дозирование антиконвульсантов. Спб.: Речь, 1999.
  4. Карлов В.А. Эпилепсия. М.: Медицина, 1990.
  5. Карлов В.А. Эпилепсия. В кн.: Яхно Н.Н. (ред.) Болезни нервной системы. В 22х т. Т. 2. М.: Медицина, 2005: 208–245.
  6. Мирошниченко И.И., Тюляев И.И., Зуев А.П. Биодоступность лекарственных средств. М.: Гамотей, 2003.
  7. Мухин К.Ю., Петрухин А.С. Идиопатические формы эпилепсии. Систематика, диагностика, терапия. М.: АрттБизнесЦентр, 2000.
  8. Соколов А.В. Терапевтический лекарственный мониторинг. Качеств. клин. практика 2002; 1: 6–11.
  9. Эди М.Ж., Тайрер Дж. Х. Противосудорожная терапия (пер. с англ.). М.: Медицина, 1983.
  10. Brodie M.J., Dichter M.A. Antiepileptic drugs. New Engl. J. Med. 1996; 334: 168–175.
  11. Bush D.M., Levine B.S., Smyth D.F. et al. A fatal intoxication involving carbamazepine, desipramine, and ethylene glycol. J. Anal. Toxicol. 1986; 10: 213–216.
  12. Gerardin A., Dubois J.P., Moppert J. et al. Absolute bioavailability of carbamazepine after oral administration of a 2% syrup. Epilepsia 1990; 31: 334–338.
  13. Goldsmith R.F., Ouvrier R.A. Salivary anticonvulsant levels in children: a comparison of methods. Ther. Drug Monit. 1981; 3: 151–157.
  14. Lertratanangkoon K., Horning M.G. Metabolism of carbamazepine. Drug Metab. Dispos. 1982; 10: 1–10.
  15. Rambeck B., Jurgens U.H., May T.V. et al. Comparison of brain extracellular fluid and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 2006; 47: 681–694.
  16. Schoeman J.F., Elyas A.A., Brett E.M., Lascelles P.T. Altered ratio of carbamazepinee10,111 epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction. Dev. Med. Child Neurol.1984; 26: 749–755.
  17. Strandjord R.E., Johannessen S.I. Singleedrug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect. Epilepsia 1980; 21: 655–662.
  18. Toseland P.A., Albani M., Gauchel F.D. Organic nitrogennselective detector used in gas chromatographic determination of some anticonvulsant and barbiturate drugs in plasma and tissues. Clin. Chem. 1975;21: 98–103.
  19. Warner A., Privitera M., Bates D. Standards of laboratory practice: antiepileptic drug monitoring. Clin. Chem. 1998, 44: 1088–1095.

Supplementary files

Supplementary Files

Copyright (c) 2008 Rodyonov A.A., Kabanova I.A., Seifulla R.D., Timofeev A.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies